moxifloxacin has been researched along with thioacetazone in 3 studies
Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (thioacetazone) | Trials (thioacetazone) | Recent Studies (post-2010) (thioacetazone) |
---|---|---|---|---|---|
3,157 | 552 | 1,690 | 699 | 47 | 29 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cho, SH; Franzblau, SG; Hwang, CH; Pauli, GF; Wan, B; Warit, S | 1 |
Aralar, P; Bermudez, LE; Inderlied, CB; Kolonoski, P; Reynolds, R; Young, LS | 1 |
Bermudez, LE; Kolonoski, P; Petrofsky, M; Reynolds, R; Seitz, LE; Wu, M; Young, LS | 1 |
3 other study(ies) available for moxifloxacin and thioacetazone
Article | Year |
---|---|
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA, Bacterial; Drug Evaluation, Preclinical; Mycobacterium tuberculosis; Oxygen | 2007 |
Thiosemicarbazole (thiacetazone-like) compound with activity against Mycobacterium avium in mice.
Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Colony Count, Microbial; Drug Therapy, Combination; Fluoroquinolones; Humans; Liver; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Quinolines; Spleen; Thioacetazone | 2003 |
SRI-286, a thiosemicarbazole, in combination with mefloquine and moxifloxacin for treatment of murine Mycobacterium avium complex disease.
Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Colony Count, Microbial; Drug Interactions; Drug Therapy, Combination; Female; Fluoroquinolones; Liver; Mefloquine; Mice; Mice, Inbred C57BL; Moxifloxacin; Mycobacterium avium-intracellulare Infection; Quinolines; Spleen; Thioacetazone | 2004 |